Navigation Links
Stago to Discuss Direct Oral Anticoagulant Screening in Webinar for the Stago EdVantage Virtual University
Date:4/20/2017

As part of the Stago EdVantage Virtual University Virtual Event, this new webinar will explore challenging patient cases when screening for direct oral anticoagulant. When patients taking direct oral anticoagulants (DOACs) are admitted to the hospital, there may be a need for bridging parental anticoagulation especially for those at high risk of thrombosis recurrence.

By presenting information on DOAC interference in laboratory assays, institutional experience, and case studies, this webinar will address questions surrounding management of patients on DOAC therapy. Attendees of this webinar will learn from instances when presented with challenging cases, and be able to show how traditional and other laboratory measures can help guide safe, appropriate therapy.

Participants will also be able to gain a better understanding of how to identify the effects of DOACs, as well as describe common errors that are seen in practice when the effect of DOACs on common anticoagulation laboratory measures is not realized.

The speaker for this event will be Dr. Michael P Gulseth, PharmD, BCPS, FASHP. He is the program director for Anticoagulation Services at Sanford USD Medical Center & Clinical. He is also an associate professor in the Department of Internal Medicine at the University of South Dakota Sanford School of Medicine.

Gulseth is a recognized expert in the area of anticoagulation administration and safety, having developed the 2017 ISMP Medication Safety Self-Assessment for Antithrombotic Therapy. He has authored numerous peer-reviewed publications in this area. In addition, he regularly serves as an editor for publications and presents at conferences of the American Society of Health-System Pharmacists (ASHP). He was elected as a fellow of the ASHP in 2011 and serves on the editorial advisory board of American Journal of Health-System Pharmacy (AJHP).

LabRoots will host the webinar April 26, 2017, commencing at 6:00 a.m. PDT. To learn more about the Stago EdVantage Virtual University Virtual Event, the continuing education credits offered, or to register for free, click here.

ABOUT DIAGNOSTICA STAGO, INC.
Diagnostica Stago, Inc. is the exclusive provider of the Diagnostica Stago Hemostasis product lines in the United States and offers a complete system of coagulation instruments and optimized reagent kits for research as well as for routine analysis. Diagnostica Stago, Inc. is the U.S. subsidiary of Diagnostica Stago, S.A.S. France, a leader in the development and manufacture of Hemostasis products. For more information about any Stago product or service, please call 800-222-COAG or visit our website at http://www.stago-us.com.

ABOUT LABROOTS
LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Read the full story at http://www.prweb.com/releases/2017/04/prweb14253391.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Stago EdVantage Virtual University Virtual Event to Offer Webinar on Preanalytical Variables in Coagulation Testing
2. LGC Maine Standards Announces Release of VALIDATE® D-Dimer Calibration Verification / Linearity Test Kit for Stago STA-R® Evolution Analyzers
3. Veracyte to Host Conference Call and Webcast to Discuss First Quarter 2017 Financial Results on Wednesday, May 3, 2017
4. Agilent Technologies Discusses New Approach to Thyroid Hormone Analysis in Upcoming Webinar
5. Orexigen Therapeutics to Provide Business Update and Discuss Fourth Quarter and Year End 2016 Financial Results on March 28, 2017
6. Asymmetrex’s Head Will Lead Discussion on Supplying Private Stem Cell Clinics at the 6th Annual Clinical Trial Supply New England 2017 Conference in Boston
7. An upcoming segment of the Rob Lowe-Hosted "Informed" Public Television Series will Discuss Climate Change
8. SCIEX Sponsors a New Webinar Discussing the Routine Use of High Resolution Mass-Spec Analysis of Pesticides in Baby Food
9. Connect with DrugDev at the SCOPE Summit for Clinical Operations Executives for Engaging Customer-Led Panel Discussions and the Anticipated Reveal of DrugDev Spark™
10. Dr. Michael A. Pfaller of T2 Biosystems to Discuss the Vital Role of Transformative Diagnostics in Optimizing Antimicrobial Stewardship in New Webinar
11. Zymo Research Discusses Standardizing Workflows when Analyzing Networks of Exchanging Antibiotic Resistance in New Webinar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2017)... ... July 17, 2017 , ... ... solutions, today announced safety software company AB Cube has joined its ... segment to advance technology innovation across life sciences and healthcare. Under the ...
(Date:7/17/2017)... ... 17, 2017 , ... DuPont Pioneer today announced the launch ... (openinnovation.pioneer.com) dedicated to connecting third-party innovators with DuPont Pioneer scientists is now available ... biologicals and digital solutions. , “DuPont Pioneer is building on its long history ...
(Date:7/14/2017)... AZ (PRWEB) , ... July 13, 2017 , ... Dr. ... for ailing dental implants into his practice, Mondlick Perio, in the Phoenix area. ... with the world's first and only FDA cleared laser treatment to re-grow bone and ...
(Date:7/13/2017)... ... 2017 , ... In’Tech Medical SAS ( http://www.intech-medical.com ), the ... of a major transaction with Eurazeo PME. The reputable French private equity comes ... In’Tech Medical’s service offerings while leveraging the company’s manufacturing expertise and global footprint. ...
Breaking Biology Technology:
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/30/2017)... 2017 The research team of The Hong ... fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery and ... speed and accuracy for use in identification, crime investigation, immigration control, ... ... A research team led ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):